Commercial Litigation and Arbitration

November 30, 2012

In re Rigel Pharm., Inc. Secs. Litig., 697 F.3d 869 (9th Cir. 2012): Neither the Supreme Court nor this court has addressed the question of whether statements concerning statistical results of a clinical trial may be considered false or misleading under Rule 10b-5 because the statistical methodology that produced those results was n ...
In re Rigel Pharm., Inc. Secs. Litig., 697 F.3d 869 (9th Cir. 2012): Neither the Supreme Court nor this court has addressed the question of whether statements concerning statistical results of a clinical trial may be considered false or misleading…

Recent Articles

Archives